Low Immunity Against COVID-19 Omicron Variants Despite 3 Vaccine Doses in Hematologic Malignancies
Researchers sought to determine the efficacy of the mRNA-based vaccination against the Omicron variant of COVID-19 in patients with hematologic malignancies.